Sign In
Buy VERX
$12.91
+0.310 (+2.46%)
At Close: Jul 31, 2026
Vertex Pharmaceuticals Likely To Report Higher Q3 Earnings; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call
02:23pm, Monday, 03'rd Nov 2025
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) will release earnings results for the first quarter, after the closing bell on Monday, Nov. 3.
Vertex: A Chance To Buy The Dip (Upgrade)
01:49pm, Monday, 03'rd Nov 2025
Vertex, Inc. shares have plunged over 60% YTD, but valuation is now compelling after a post-earnings dip. VERX offers steady low-teens growth, expanding margins, and a sticky tax compliance software p
Kimberly-Clark, Vertex And Other Big Stocks Moving Lower In Monday's Pre-Market Session
08:14am, Monday, 03'rd Nov 2025
U.S. stock futures were mixed this morning, with the Nasdaq futures gaining more than 100 points on Monday.
Vertex Announces Third Quarter 2025 Financial Results and $150 Million Class A Common Stock Repurchase Program
07:05am, Monday, 03'rd Nov 2025
KING OF PRUSSIA, Pa., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Vertex, Inc. (NASDAQ: VERX) (“Vertex” or the “Company”), a leading global provider of indirect tax solutions, today announced financial
Vertex Appoints New Leader in Europe to Advance Product Innovation and Strengthen Compliance
04:00am, Thursday, 30'th Oct 2025
Industry expert Ralf Gärtner joins as SVP and Regional Manager to spearhead Vertex's global operations Industry expert Ralf Gärtner joins as SVP and Regional Manager to spearhead Vertex's global ope
Vertex Gears Up to Report Q3 Earnings: Is a Beat in the Cards?
12:56pm, Tuesday, 28'th Oct 2025
Strong Trikafta/Kaftrio demand, along with contributions from Alyftrek, Casgevy and Journavx, may have helped VRTX outperform in the third quarter.
Vertex Pharmaceuticals Remains A Buy Heading Into Q3 Earnings
11:59am, Tuesday, 28'th Oct 2025
Vertex Pharmaceuticals Incorporated remains a leader in cystic fibrosis treatments, fueling robust cash flow and funding a promising pipeline expansion. VRTX is seeing early but accelerating revenue f
Vertex to Participate in the UBS Global Healthcare Conference on November 11
04:00pm, Monday, 27'th Oct 2025
BOSTON--(BUSINESS WIRE)--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced management participation in the UBS Global Healthcare Conference. Reshma Kewalramani, President and Chief Ex
Vertex (VERX) Earnings Expected to Grow: Should You Buy?
11:06am, Monday, 27'th Oct 2025
Vertex (VERX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Prediction: Vertex Pharmaceuticals Will Be Worth More Than Pfizer by 2030
05:43am, Monday, 27'th Oct 2025
Pfizer is racing towards patent cliffs that will lead to even worse financial results. Vertex Pharmaceuticals is posting strong revenue growth and excellent clinical progress.
Growth Fund Dumps $25 Million in Vertex Stock as Weak Quarter Hit Returns
01:53pm, Sunday, 26'th Oct 2025
Pennsylvania-based Conestoga Capital Advisors sold 855,435 Vertex shares for an estimated $24.8 million based on average prices for the quarter ended September 30. The change represents 0.4% of 13F re
Wall Street Analysts Believe Vertex (VERX) Could Rally 44.47%: Here's is How to Trade
10:56am, Thursday, 23'rd Oct 2025
The mean of analysts' price targets for Vertex (VERX) points to a 44.5% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts
BOSTON--(BUSINESS WIRE)--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced several important updates across its development program for povetacicept (pove), an investigational recombi
Vertex Achieves Oracle Validated Integration for Delivering a Proven, Repeatable Integration for Oracle's ERP Solution
11:00am, Tuesday, 14'th Oct 2025
Vertex Accelerator for Oracle's ERP offering gives customers an embedded, push-button integration with a powerful user interface, flexible mapping and accurate tax calculation to accelerate time to va
Vertex and Kintsugi Launch AI-Powered Tax Automation Solution: Kintsugi powered by Vertex
08:00am, Wednesday, 08'th Oct 2025
KING OF PRUSSIA, Pa., Oct. 08, 2025 (GLOBE NEWSWIRE) -- Vertex Inc. (NASDAQ:VERX) (“Vertex” or the “Company”), a global provider of indirect tax solutions, today announced the launch of Kintsu
